Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SBC
SBC logo

SBC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SBC Medical Group Holdings Inc (SBC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.960
1 Day change
52 Week Range
5.750
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

SBC Medical Group Holdings Inc is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical support, but there is no clear catalyst, no recent news, no supportive options data, and no strong proprietary signal. My direct view is to hold off rather than buy immediately.

Technical Analysis

The current trend is mixed to slightly constructive short term. MACD histogram is positive and expanding, which supports mild bullish momentum. RSI_6 at 63.654 is neutral-to-slightly elevated, not overbought but not deeply attractive for a fresh long-term entry. Moving averages are converging, which suggests the stock is near a decision zone rather than in a strong trend. Key levels: pivot 3.126, resistance at 3.291 and 3.392, support at 2.962 and 2.861. The latest close at 3.09 is slightly below the pivot, so momentum is not strong enough to justify an aggressive long-term buy.

Positive Catalysts

  • ["MACD histogram is positive and expanding, indicating improving momentum.", "Stock has a neutral trading backdrop with no obvious negative event pressure.", "Historical pattern estimate suggests some upside over the next month."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no clear event-driven catalyst.", "Hedge funds are neutral with no significant trading trends over the last quarter.", "Insiders are neutral with no significant trading trends over the last month.", "No recent congress trading data available.", "No valuation data and financial snapshot error reduce confidence in fundamentals.", "AI Stock Picker shows no signal and SwingMax shows no recent signal."]

Financial Performance

No usable latest-quarter financial snapshot was provided because the financial data returned an error. As a result, there is no reliable quarterly revenue, earnings, or growth trend to assess for SBC's latest quarter season.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible recent Wall Street upgrade/downgrade trend or target revision trend to support a bullish or bearish view.

Wall Street analysts forecast SBC stock price to rise
1 Analyst Rating
Wall Street analysts forecast SBC stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.960
sliders
Low
9
Averages
9
High
9
Current: 2.960
sliders
Low
9
Averages
9
High
9
BTIG
Sam Eiber
initiated
$8
AI Analysis
2026-03-06
Reason
BTIG
Sam Eiber
Price Target
$8
AI Analysis
2026-03-06
initiated
Reason
BTIG analyst Sam Eiber initiated coverage of SBC Medical Group with a Buy rating and $8 price target. SBC is the leading aesthetic medical group in Japan with more than 250 franchises and over 6.5M annual patient visits, the analyst tells investors in a research note. The firm says the shares represent an opportunity for investors looking to own an outside of the U.S. business that has "numerous growth prospects" and is trading at a discount to peers.
Maxim
Maxim
initiated
$9
2025-11-05
Reason
Maxim
Maxim
Price Target
$9
2025-11-05
initiated
Reason
Maxim initiated coverage of SBC Medical Group with a Buy rating and $9 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SBC
Unlock Now

People Also Watch